Slutsky Andrew 4

4 · GoodRx Holdings, Inc. · Filed Jan 4, 2022

Form 4

Period: 2022-01-01

President, Consumer

Transactions

Exercise/Conversion
Restricted Stock Units
2022-01-01−62,500→ 687,500 total
→ Class A Common Stock (62,500 underlying)
Exercise/Conversion
Class A Common Stock
2022-01-01+62,500→ 2,947,029 total
Sale
Class A Common Stock
2022-01-03$32.10/sh−21,625$694,169→ 2,898,733 total
Tax Payment
Class A Common Stock
2022-01-01$32.68/sh−26,671$871,608→ 2,920,358 total
Sale
Class A Common Stock
2022-01-03$32.85/sh−14,204$466,627→ 2,884,529 total

Holdings

Footnotes (6)

[F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
[F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted September 1, 2021.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.63 to $32.62, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.64 to $33.14, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F5]Shares held by The Arisa Slutsky Spousal Trust.
[F6]On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date.

Documents

1 file